Skip to main content
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1990 Mar;65(3):301–303. doi: 10.1136/adc.65.3.301

Langerhans cell histiocytosis: the case for conservative treatment.

J McLelland 1, V Broadbent 1, E Yeomans 1, M Malone 1, J Pritchard 1
PMCID: PMC1792292  PMID: 2334209

Abstract

Fifty eight children with Langerhans cell histiocytosis who were referred to this hospital between 1980 and 1987 were studied. Fourteen had single system disease, and 44 had multisystem disease, of whom 22 had vital organ dysfunction. A conservative approach to treatment was adopted, and when systemic treatment was indicated a short course of prednisolone was used first. Eight of the patients with single system disease required no treatment, while six received local treatment alone. Eight of the patients with multisystem disease did not require systemic treatment, 17 were given prednisolone alone, and 19 were given cytotoxic drugs. Of the 14 with single system disease 13 had no long term after effects. Eight of the patients with multisystem disease died, 24 had long term after effects, and 12 had none. Outcome was related to age and Lahey score. These results compare favourably with other series in which more aggressive approaches were used, and support our conservative approach to treatment.

Full text

PDF
301

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Broadbent V., Pritchard J. Histiocytosis X--current controversies. Arch Dis Child. 1985 Jul;60(7):605–607. doi: 10.1136/adc.60.7.605. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Gadner H., Heitger A., Ritter J., Göbel U., Janka G. E., Kühl J., Bode U., Spaar H. J. Langerhanszell-Histiozytose im Kindesalter--Ergebnisse der DAL-HX 83 Studie. Klin Padiatr. 1987 May-Jun;199(3):173–182. doi: 10.1055/s-2008-1026785. [DOI] [PubMed] [Google Scholar]
  3. Greenberger J. S., Crocker A. C., Vawter G., Jaffe N., Cassady J. R. Results of treatment of 127 patients with systemic histiocytosis. Medicine (Baltimore) 1981 Sep;60(5):311–338. doi: 10.1097/00005792-198109000-00001. [DOI] [PubMed] [Google Scholar]
  4. Lahey E. Histiocytosis x--an analysis of prognostic factors. J Pediatr. 1975 Aug;87(2):184–189. doi: 10.1016/s0022-3476(75)80576-2. [DOI] [PubMed] [Google Scholar]
  5. McLelland J., Newton J., Malone M., Camplejohn R. S., Chu A. C. A flow cytometric study of Langerhans cell histiocytosis. Br J Dermatol. 1989 Apr;120(4):485–491. doi: 10.1111/j.1365-2133.1989.tb01321.x. [DOI] [PubMed] [Google Scholar]
  6. Sims D. G. Histiocytosis X; follow-up of 43 cases. Arch Dis Child. 1977 Jun;52(6):433–440. doi: 10.1136/adc.52.6.433. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Toogood I. R., Ellis W. M., Ekert H. Prognostic criteria, treatment and survival in disseminated histiocytosis X. Aust Paediatr J. 1979 Jun;15(2):91–95. doi: 10.1111/j.1440-1754.1979.tb01196.x. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES